Trial Mammatherm

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

Mammatherm

Full title

Prospektiv randomisierte Phase I/II Studie mit liposomalem Doxorubicin und Cisplatin +/- lokoregionale Hyperthermie bei Patientinnen mit metastasiertem Brustkrebs

EudraCT number

2005-005862-36

Responsible organization

Medizinische Klinik III, Telefon: 089440072551

Indications

Classification	Code	Description
ICD-10-GM	C50.-	Bösartige Neubildung der Brustdrüse [Mamma]
-		Breastcancer

Trial design

Trial type

Interventional

Blinding type

Open

Phase

I/II

Status

Trial finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

2013-12-31 / Unknown

Participants

	Function	Prename	Surname	Organization
	Principal Investigator	VOLKER	HEINEMANN	Keine Organisationseinheit angegeben